{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:06:00Z","timestamp":1793300760689,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T00:00:00Z","timestamp":1626652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T00:00:00Z","timestamp":1626652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In inflammatory bowel disease (IBD), the chronic inflammation deeply affects the intestinal extracellular matrix. The aim of this study was to investigate if remodeling of the intestinal basement membrane type VI collagen was associated with pathophysiological changes in Crohn\u2019s disease (CD) and ulcerative colitis (UC). Serum from IBD patients (CD: n\u2009=\u200965; UC: n\u2009=\u2009107; irritable bowel syndrome: n\u2009=\u200918; healthy subjects: n\u2009=\u200920) was investigated in this study. The serological biomarkers C6Ma3 (a matrix metalloproteinase (MMP) generated fragment of the type VI collagen \u03b13 chain) and PRO-C6, also called endotrophin (the C-terminus of the released C5 domain of the type VI collagen \u03b13 chain) were measured by ELISAs. Serum C6Ma3 was increased in CD patients with moderate to severe and mild endoscopically active disease compared to endoscopic remission (p\u2009=\u20090.002, p\u2009=\u20090.0048), respectively, and could distinguish endoscopically active disease from remission with an AUC of 1.0 (sensitivity: 100%, specificity: 100%) (p\u2009&lt;\u20090.0001), which was superior to CRP. C6Ma3 was increased in CD patients with moderate to severe clinical disease compared to mild and remission (p\u2009=\u20090.04; p\u2009=\u20090.009). Serum PRO-C6, endotrophin, was increased in CD patients in clinically remission compared to mild disease (p\u2009=\u20090.04) and moderate to severe disease (p\u2009=\u20090.065). In UC, fecal calprotectin was the only marker that alone could distinguish both clinical and endoscopic active and inactive disease. Type VI collagen degradation of the \u03b13 chain mediated by MMPs was increased in CD patients with endoscopically active disease, measured by the serological biomarker C6Ma3, which was able to distinguish endoscopically active from inactive CD.<\/jats:p>","DOI":"10.1038\/s41598-021-94321-2","type":"journal-article","created":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T10:03:18Z","timestamp":1626688998000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Endotrophin and C6Ma3, serological biomarkers of type VI collagen remodelling, reflect endoscopic and clinical disease activity in IBD"],"prefix":"10.1038","volume":"11","author":[{"given":"Majken","family":"Lindholm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Line E.","family":"Godskesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Manon-Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Kjeldsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander","family":"Krag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten A.","family":"Karsdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim H.","family":"Mortensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,19]]},"reference":[{"key":"94321_CR1","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/MOG.0000000000000368","volume":"33","author":"AC Petrey","year":"2017","unstructured":"Petrey, A. C. & de la Motte, C. A. The extracellular matrix in IBD. Curr. Opin. Gastroenterol. 33, 234\u2013238 (2017).","journal-title":"Curr. Opin. Gastroenterol."},{"key":"94321_CR2","doi-asserted-by":"publisher","first-page":"11246","DOI":"10.3748\/wjg.v21.i40.11246","volume":"21","author":"S Chang","year":"2015","unstructured":"Chang, S., Malter, L. & Hudesman, D. Disease monitoring in inflammatory bowel disease. World J. Gastroenterol. 21, 11246\u201311259 (2015).","journal-title":"World J. Gastroenterol."},{"key":"94321_CR3","first-page":"1","volume":"10","author":"M Krzystek-Korpacka","year":"2020","unstructured":"Krzystek-Korpacka, M. et al. Biochemical biomarkers of mucosal healing for inflammatory bowel disease in adults. Diagnostics. 10, 1\u201331 (2020).","journal-title":"Diagnostics."},{"key":"94321_CR4","first-page":"529","volume":"15","author":"MF Picco","year":"2019","unstructured":"Picco, M. F. & Farraye, F. A. Targeting mucosal healing in Crohn\u2019s disease. Gastroenterol. Hepatol. (N. Y). 15, 529\u2013538 (2019).","journal-title":"Gastroenterol. Hepatol. (N. Y)."},{"key":"94321_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrgastro.2009.203","volume":"7","author":"GP De Chambrun","year":"2010","unstructured":"De Chambrun, G. P. et al. Clinical implications of mucosal healing for the management of IBD. Nat. Rev. Gastroenterol. Hepatol. 7, 15\u201329 (2010).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"94321_CR6","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/j.1572-0241.2007.01556.x","volume":"103","author":"J Langhorst","year":"2008","unstructured":"Langhorst, J. et al. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: Performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. Am. J. Gastroenterol. 103, 162\u2013169 (2008).","journal-title":"Am. J. Gastroenterol."},{"key":"94321_CR7","doi-asserted-by":"crossref","unstructured":"Lobat\u00f3n, T., Bessissow, T., De Hertogh, G., et al. The Modified Mayo Endoscopic Score (MMES): A New Index for the Assessment of Extension and Severity of Endoscopic Activity in Ulcerative Colitis Patients. J. Crohns. Colitis. 846\u2013852 (2015).","DOI":"10.1093\/ecco-jcc\/jjv111"},{"key":"94321_CR8","doi-asserted-by":"crossref","unstructured":"Klenske, E., Bojarski, C., Waldner, M., et al. Targeting mucosal healing in Crohn\u2019s disease: What the clinician needs to know. Ther Adv Gastroenterol. 12, 1\u201311 (2019).","DOI":"10.1177\/1756284819856865"},{"key":"94321_CR9","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1080\/17474124.2019.1673729","volume":"13","author":"JH Mortensen","year":"2019","unstructured":"Mortensen, J. H. et al. The intestinal tissue homeostasis\u2014The role of extracellular matrix remodeling in inflammatory bowel disease. Expert Rev. Gastroenterol. Hepatol. 13, 977\u2013993. https:\/\/doi.org\/10.1080\/17474124.2019.1673729 (2019).","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"94321_CR10","doi-asserted-by":"crossref","unstructured":"Karsdal, M.A., Nielsen, S.H., Leeming, D.J., et al. The good and the bad collagens of fibrosis\u2014their role in signaling and organ function. Adv. Drug Deliv. Rev. 121, 43\u201356 (2017).","DOI":"10.1016\/j.addr.2017.07.014"},{"key":"94321_CR11","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1136\/gut.37.6.805","volume":"37","author":"J Kjeldsen","year":"1995","unstructured":"Kjeldsen, J., de Muckadell, O. B. S. & Junker, P. Seromarkers of collagen I and III metabolism in active Crohn\u2019s disease. Relation to disease activity and response to therapy. Gut 37, 805\u2013810 (1995).","journal-title":"Gut"},{"key":"94321_CR12","doi-asserted-by":"publisher","first-page":"e0185855","DOI":"10.1371\/journal.pone.0185855","volume":"12","author":"JH Mortensen","year":"2017","unstructured":"Mortensen, J. H. et al. Ulcerative colitis, Crohn\u2019s disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn\u2019s disease. PLoS ONE 12, e0185855. https:\/\/doi.org\/10.1371\/journal.pone.0185855 (2017).","journal-title":"PLoS ONE"},{"key":"94321_CR13","doi-asserted-by":"publisher","unstructured":"Mortensen, J.H., Godskesen, L.E., Jensen, M.D., et al. Fragments of citrullinated and MMP-degraded vimentin and MMP-degraded type III collagen are novel serological biomarkers to differentiate Crohn\u2019s disease from ulcerative colitis. J. Crohn\u2019s Colitis. 1\u201310. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjv123 (2015).","DOI":"10.1093\/ecco-jcc\/jjv123"},{"key":"94321_CR14","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/apt.14092","volume":"46","author":"HWT Van","year":"2017","unstructured":"Van, H. W. T. et al. Misbalance in type III collagen formation\/degradation as a novel serological biomarker for penetrating (Montreal B3) Crohn\u2019s disease. Aliment. Pharmacol. Ther. 46, 26\u201339 (2017).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"94321_CR15","doi-asserted-by":"publisher","first-page":"3134","DOI":"10.1007\/s10620-019-05676-6","volume":"64","author":"M Lindholm","year":"2019","unstructured":"Lindholm, M. et al. Extracellular matrix fragments of the basement membrane and the interstitial matrix are serological markers of intestinal tissue remodeling and disease activity in dextran sulfate sodium colitis. Dig. Dis. Sci. 64, 3134\u20133142 (2019).","journal-title":"Dig. Dis. Sci."},{"key":"94321_CR16","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.11.029","volume-title":"Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice with Chronic Intestinal Inflammation","author":"K Scheibe","year":"2018","unstructured":"Scheibe, K. et al. Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice with Chronic Intestinal Inflammation (The American Gastroenterological Association, 2018). https:\/\/doi.org\/10.1053\/j.gastro.2018.11.029."},{"key":"94321_CR17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0022-4804(02)00094-X","volume":"109","author":"S Groos","year":"2003","unstructured":"Groos, S. et al. Changes in epithelial cell turnover and extracellular matrix in human small intestine after TPN. J. Surg. Res. 109, 74\u201385 (2003).","journal-title":"J. Surg. Res."},{"key":"94321_CR18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.matbio.2011.03.002","volume":"30","author":"JF Groulx","year":"2011","unstructured":"Groulx, J. F. et al. Collagen VI is a basement membrane component that regulates epithelial cell-fibronectin interactions. Matrix Biol. 30, 195\u2013206. https:\/\/doi.org\/10.1016\/j.matbio.2011.03.002 (2011).","journal-title":"Matrix Biol."},{"key":"94321_CR19","doi-asserted-by":"publisher","first-page":"5155","DOI":"10.1210\/jc.2009-0947","volume":"94","author":"M Pasarica","year":"2009","unstructured":"Pasarica, M. et al. Adipose tissue collagen VI in obesity. J. Clin. Endocrinol. Metab. 94, 5155\u20135162 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"94321_CR20","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1002\/j.1460-2075.1986.tb04573.x","volume":"5","author":"B Tr\u00fceb","year":"1986","unstructured":"Tr\u00fceb, B. & Winterhalter, K. H. Type VI collagen is composed of a 200 kd subunit and two 140 kd subunits. EMBO J. 5, 2815\u20132819 (1986).","journal-title":"EMBO J."},{"key":"94321_CR21","doi-asserted-by":"publisher","first-page":"16607","DOI":"10.1074\/jbc.M510192200","volume":"281","author":"SR Lamand\u00e9","year":"2006","unstructured":"Lamand\u00e9, S. R. et al. The C5 domain of the collagen VI \u03b13(VI) chain is critical for extracellular microfibril formation and is present in the extracellular matrix of cultured cells. J. Biol. Chem. 281, 16607\u201316614 (2006).","journal-title":"J. Biol. Chem."},{"key":"94321_CR22","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1002\/j.1460-2075.1989.tb03598.x","volume":"8","author":"ML Chu","year":"1989","unstructured":"Chu, M. L. et al. Sequence analysis of alpha 1(VI) and alpha 2(VI) chains of human type VI collagen reveals internal triplication of globular domains similar to the A domains of von Willebrand factor and two alpha 2(VI) chain variants that differ in the carboxy terminus. EMBO J. 8, 1939\u20131946 (1989).","journal-title":"EMBO J."},{"key":"94321_CR23","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1042\/bj2110303","volume":"211","author":"H Furthmayr","year":"1983","unstructured":"Furthmayr, H. et al. Electron-microscopical approach to a structural model of intima collagen. Biochem. J. 211, 303\u2013311 (1983).","journal-title":"Biochem. J."},{"key":"94321_CR24","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1432-1033.1984.tb08313.x","volume":"142","author":"H Von Der Mark","year":"1984","unstructured":"Von Der Mark, H. et al. Immunochemistry, genuine size and tissue localization of collagen VI. Eur. J. Biochem. 142, 493\u2013502 (1984).","journal-title":"Eur. J. Biochem."},{"key":"94321_CR25","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1083\/jcb.102.3.703","volume":"102","author":"E Engvall","year":"1986","unstructured":"Engvall, E., Hessle, H. & Klier, G. Molecular assembly, secretion, and matrix deposition of type VI collagen. J. Cell Biol. 102, 703\u2013710 (1986).","journal-title":"J. Cell Biol."},{"key":"94321_CR26","doi-asserted-by":"crossref","unstructured":"Cescon, M., Gattazzo, F., Chen, P., et al. Collagen VI at a glance. J. Cell Sci. 128, 3525\u20133531 (2015).","DOI":"10.1242\/jcs.169748"},{"key":"94321_CR27","doi-asserted-by":"publisher","first-page":"26522","DOI":"10.1074\/jbc.272.42.26522","volume":"272","author":"HJ Kuo","year":"1997","unstructured":"Kuo, H. J. et al. Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen. J. Biol. Chem. 272, 26522\u201326529 (1997).","journal-title":"J. Biol. Chem."},{"key":"94321_CR28","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1021\/bi00457a021","volume":"29","author":"P Bonaldo","year":"1990","unstructured":"Bonaldo, P. et al. Structural and functional features of the \u03b13 chain indicate a bridging role for chicken collagen VI in connective tissues. Biochemistry 29, 1245\u20131254 (1990).","journal-title":"Biochemistry"},{"key":"94321_CR29","doi-asserted-by":"publisher","first-page":"5250","DOI":"10.1016\/S0021-9258(18)42759-7","volume":"267","author":"DJ Bidanset","year":"1992","unstructured":"Bidanset, D. J. et al. Binding of the proteoglycan decorin to collagen type VI. J. Biol. Chem. 267, 5250\u20135256 (1992).","journal-title":"J. Biol. Chem."},{"key":"94321_CR30","doi-asserted-by":"publisher","first-page":"37698","DOI":"10.1074\/jbc.M304638200","volume":"278","author":"C Wiberg","year":"2003","unstructured":"Wiberg, C. et al. Complexes of matrilin-1 and biglycan or decorin connect collagen VI microfibrils to both collagen II and aggrecan. J. Biol. Chem. 278, 37698\u201337704 (2003).","journal-title":"J. Biol. Chem."},{"key":"94321_CR31","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/0014-4827(89)90103-1","volume":"181","author":"M Aumailley","year":"1989","unstructured":"Aumailley, M. et al. Cell attachment properties of collagen type VI and arg-gly-asp dependent binding to its \u03b12(VI) and \u03b13(VI) chains. Exp. Cell Res. 181, 463\u2013474 (1989).","journal-title":"Exp. Cell Res."},{"key":"94321_CR32","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1006\/bbrc.2001.6227","volume":"290","author":"T Aigner","year":"2002","unstructured":"Aigner, T. et al. The C5 domain of Col6a3 is cleaved off from the Col6 fibrils immediately after secretion. Biochem. Biophys. Res. Commun. 290, 743\u2013748 (2002).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"94321_CR33","doi-asserted-by":"publisher","first-page":"4243","DOI":"10.1172\/JCI63930","volume":"122","author":"J Park","year":"2012","unstructured":"Park, J. & Scherer, P. E. Adipocyte-derived endotrophin promotes malignant tumor progression. J. Clin. Invest. 122, 4243\u20134256 (2012).","journal-title":"J. Clin. Invest."},{"key":"94321_CR34","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1039\/C8MO00239H","volume":"15","author":"S Kirov","year":"2019","unstructured":"Kirov, S. et al. Degradation of the extracellular matrix is part of the pathology of ulcerative colitis. Mol. Omi. 15, 67\u201376 (2019).","journal-title":"Mol. Omi."},{"key":"94321_CR35","first-page":"1","volume":"10","author":"S Sun","year":"2015","unstructured":"Sun, S. et al. Collagen type III and VI turnover in response to long-term immobilization. PLoS ONE 10, 1\u201314 (2015).","journal-title":"PLoS ONE"},{"key":"94321_CR36","doi-asserted-by":"crossref","unstructured":"Nielsen, S.H., Mortensen, J.H., Willumsen, N., et al. A fragment of collagen type VI alpha-3 chain is elevated in serum from patients with gastrointestinal disorders. Sci. Rep.10(5910), 1\u201327 (2020).","DOI":"10.1038\/s41598-020-62474-1"},{"key":"94321_CR37","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.tranon.2019.02.004","volume":"12","author":"N Willumsen","year":"2019","unstructured":"Willumsen, N., Bager, C. & Karsdal, M. A. Matrix metalloprotease generated fragments of type VI collagen have serum biomarker potential in cancer\u2014A proof of concept study. Transl. Oncol. 12, 693\u2013698. https:\/\/doi.org\/10.1016\/j.tranon.2019.02.004 (2019).","journal-title":"Transl. Oncol."},{"key":"94321_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0175898","volume":"12","author":"EGD Stribos","year":"2017","unstructured":"Stribos, E. G. D. et al. Non-invasive quantification of collagen turnover in renal transplant recipients. PLoS ONE 12, 1\u201311 (2017).","journal-title":"PLoS ONE"},{"key":"94321_CR39","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.2337\/dc17-2392","volume":"41","author":"DGK Rasmussen","year":"2018","unstructured":"Rasmussen, D. G. K. et al. Higher collagen VI formation is associated with all-cause mortality in patients with type 2 diabetes and microalbuminuria. Diabetes Care 41, 1493\u20131500 (2018).","journal-title":"Diabetes Care"},{"key":"94321_CR40","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.2337\/dc18-2599","volume":"42","author":"S Pilemann-Lyberg","year":"2019","unstructured":"Pilemann-Lyberg, S. et al. Markers of collagen formation and degradation reflect renal function and predict adverse outcomes in patients with type 1 diabetes. Diabetes Care 42, 1760\u20131768 (2019).","journal-title":"Diabetes Care"},{"key":"94321_CR41","doi-asserted-by":"crossref","unstructured":"Organ, L., Duggan, A.-M., Oballa, E., et al. Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort. Respir. Res. 20, 148 (2019).","DOI":"10.1186\/s12931-019-1118-7"},{"key":"94321_CR42","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1177\/2047487318758750","volume":"25","author":"SH Nielsen","year":"2018","unstructured":"Nielsen, S. H. et al. Accelerated collagen turnover in women with angina pectoris without obstructive coronary artery disease: An iPOWER substudy. Eur. J. Prev. Cardiol. 25, 719\u2013727 (2018).","journal-title":"Eur. J. Prev. Cardiol."},{"key":"94321_CR43","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0016-5107(04)01878-4","volume":"60","author":"M Daperno","year":"2004","unstructured":"Daperno, M. et al. Development and validation of a new, simplified endoscopic activity score for Crohn\u2019s disease: The SES-CD. Gastrointest. Endosc. 60, 505\u2013512 (2004).","journal-title":"Gastrointest. Endosc."},{"key":"94321_CR44","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","volume":"317","author":"KW Schroeder","year":"1987","unstructured":"Schroeder, K. W., Tremaine, W. J. & Ilstrup, D. M. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis\u2014A randomized study. N. Engl. J. Med. 317, 1625\u20131629 (1987).","journal-title":"N. Engl. J. Med."},{"key":"94321_CR45","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1097\/01.MIB.0000173271.18319.53","volume":"11","author":"CA Solem","year":"2005","unstructured":"Solem, C. A. et al. Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Inflamm. Bowel Dis. 11, 707\u2013712 (2005).","journal-title":"Inflamm. Bowel Dis."},{"key":"94321_CR46","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1136\/gut.27.7.809","volume":"27","author":"SH Saverymuttu","year":"1986","unstructured":"Saverymuttu, S. H. et al. Differing acute phase responses in Crohn\u2019s disease and ulcerative colitis. Gut 27, 809\u2013813 (1986).","journal-title":"Gut"},{"key":"94321_CR47","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1177\/2050640618784046","volume":"6","author":"C Reenaers","year":"2018","unstructured":"Reenaers, C. et al. Expert opinion for use of faecal calprotectin in diagnosis and monitoring of inflammatory bowel disease in daily clinical practice. United Eur. Gastroenterol. J. 6, 1117\u20131125. https:\/\/doi.org\/10.1177\/2050640618784046 (2018).","journal-title":"United Eur. Gastroenterol. J."},{"key":"94321_CR48","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1053\/j.gastro.2018.11.029","volume":"156","author":"K Scheibe","year":"2019","unstructured":"Scheibe, K. et al. Inhibiting interleukin 36 receptor signaling reduces fibrosis in mice with chronic intestinal inflammation. Gastroenterology 156, 1082-1097.e11. https:\/\/doi.org\/10.1053\/j.gastro.2018.11.029 (2019).","journal-title":"Gastroenterology"},{"key":"94321_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2014.00462","volume":"5","author":"LI Kredel","year":"2014","unstructured":"Kredel, L. I. & Siegmund, B. Adipose-tissue and intestinal inflammation\u2014Visceral obesity and creeping fat. Front. Immunol. 5, 1\u201312 (2014).","journal-title":"Front. Immunol."},{"key":"94321_CR50","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/JID.2015.352","volume":"136","author":"G Theocharidis","year":"2016","unstructured":"Theocharidis, G. et al. Type VI collagen regulates dermal matrix assembly and fibroblast motility. J. Invest. Dermatol. 136, 74\u201383. https:\/\/doi.org\/10.1038\/JID.2015.352 (2016).","journal-title":"J. Invest. Dermatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94321-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94321-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94321-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T11:42:20Z","timestamp":1670067740000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94321-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,19]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["94321"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-94321-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,19]]},"assertion":[{"value":"23 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"ML, TMJ, MAK, and JHM are full-time employees at Nordic Bioscience. TMJ and MAK hold stocks in Nordic Bioscience. Nordic Bioscience is a privately owned small-medium sized enterprise, partly focused in the development of biomarkers for connective tissue disorders and rheumatic diseases. None of the authors received any kind of financial benefits or other bonuses for the work described in this manuscript. LEG, AK and JK have no financial disclosures and conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14713"}}